This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers have found that under certain conditions, a laser beam can act like an opaque object and cast a shadow, opening new possibilities for technologies that could use a laser beam to control another laser beam.
The company is paying China-based biotech LaNova Medicines $588 million for the type of dual-pronged antibody drug that recently bested Keytruda in a clinical trial.
Researchers have created a headphone prototype that allows listeners to hear people speaking within a bubble with a programmable radius of 3 to 6 feet. Voices and sounds outside the bubble are quieted an average of 49 decibels, even if they're louder than those in the bubble.
A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
THURSDAY, Nov. 14, 2024 -- Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among children under 5.Now, there's troubling news that the malaria parasite may be gaining resistance.
New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics. The anti-anxiety andhallucination-inducing qualities of psychedelic drugs work through different neural circuits, according to research using a mouse model.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics. The anti-anxiety andhallucination-inducing qualities of psychedelic drugs work through different neural circuits, according to research using a mouse model.
THURSDAY, Nov. 14, 2024 -- Periodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn.“Recent research has shown that diabetes is not only a major risk factor for periodontitis but that t.
Scientists have found a trigger for social learning in wild animals. An experiment on great t**s has pinpointed a single factor --immigration -- that can cause birds to pay close attention to others, leading them to rapidly adopt useful behaviors. The study is the first to provide experimental support of a long-held assumption that immigrants should strategically use social learning.
THURSDAY, Nov. 14, 2024 -- Using abbreviations while texting might save some typing time, but it won't make a good impression, a new study finds.People who use texting abbreviations like IDK or GOAT are perceived as more insincere and are less.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
THURSDAY, Nov. 14, 2024 -- An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and effective against triple-negative.
THURSDAY, Nov. 14, 2024 -- Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the blood sugar disease since 1990, new statistics show.Type 2 diabetes, which makes up 95% of cases.
In an era where clinical trials are increasingly global, it’s more imperative than ever to leverage international expertise. Data and safety monitoring boards (DSMBs), also known as data monitoring committees (DMCs), play a critical role in overseeing a clinical trial’s safety and efficacy. These independent committees are entrusted with the task of safeguarding study participant’s interests while ensuring the trial’s scientific integrity.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
THURSDAY, Nov. 14, 2024 (HealthDay news) -- Don't think your doctor is always taking your health concerns seriously? You might be right.New research reveals that primary care physicians frequently won’t write down health issues raised by patients i.
A new technique allows researchers to separate external and internal DNA to identify microbes colonizing the hostile environment of the Atacama Desert.
THURSDAY, Nov. 14, 2024 -- Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked.Among a group of more than 200 low-income patients who were treated at community health centers, 3 of 4 had.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
THURSDAY, Nov. 14, 2024 -- A trio of risk factors not only increase your risk of stroke, but they also raise the odds that such a stroke will be debilitating, a new study warns.What are these three big dangers? Smoking, having high blood pressure.
By Ricardo Carvajal — Among the more interesting developments in the recent election was the emergency of Robert Kennedy as a prominent figure in the MAGA movement – and the collateral emergence of the MAHA movement (Make America Healthy Again). As crisply laid out in short YouTube video , MAHA aims to transform public health by zeroing in on “our nation’s biggest health challenge – chronic disease.
THURSDAY, Nov. 14, 2024 -- The number of Americans sickened in an E. coli outbreak tied to slivered onions used on McDonald's Quarter Pounders has now risen to 104, U.S. health officials reported Wednesday.In an update posted on its website, the.
As we approach 2025, biomarker analysis in the preclinical stage is poised for transformative changes, driven by advances in technology, data science, and evolving regulatory frameworks. These innovations promise to enhance the precision and efficacy of early-stage research, setting a solid foundation for subsequent clinical applications and enabling the development of more personalized medicine.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
THURSDAY, Nov. 14, 2024 -- More than a third of surgical patients develop complications as a result of their procedure, a new study shows.About 38% of adult patients suffer an adverse event during or following their surgery, researchers reported.
If you are searching for a way to accelerate your drug product development timelines, it is recommended you speak with a consultant. Discover why here!
THURSDAY, Nov. 14, 2024 -- After decades of battling the opioid epidemic, U.S. health officials reported Wednesday that overdose deaths have now declined for the second year in a row.By how much did these deaths of despair drop? There were about.
Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and highlight how our colleagues work together on our higher purpose to improve patient health and safety throughout the complete product lifecycle.
A new study determines that just four policies can reduce mismanaged plastic waste -- plastic that isn't recycled or properly disposed of and ends up as pollution -- by 91% and plastic-related greenhouse gasses by one-third. The policies are: mandate new products be made with 40% post-consumer recycled plastic; cap new plastic production at 2020 levels; invest significantly in plastic waste management -- such as landfills and waste collection services; and implement a small fee on plastic packag
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content